The elevated serum levels of IL-6 in COVID-19 patients and its circulating levels are positively correlated with the severity of disease, indicating that IL-6 plays a key role in the pathogenesis of CRS (McGonagle et al., 2020; Ragab et al., 2020; Zhang et al., 2020). This evidence concerns the gene IL6 and COVID-19.